Active Pediatric Neonatology Clinical Trials
Pediatric Clinical Trials Main Page
Further protocol information can be found on the links below at ClinicalTrials.gov
Title: A Phase 2b/3, Multi-Center, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight (VLBW) Neonates for the Prevention of Staphylococcal Sepsis
Decscription: Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis
Investigator: Steve Goldman, MD
Eligibility: Neonates up to 48 hours of age
Status: Closed to enrollment
Contact: Chanel Durley, 415-600-3246,
Email: DurleyC@cpmcri.org about Study Biosynexus MAB-N007
- updated March 2012
Back to top